Encouragingly, our pilot study uncovered the aberrantly high expression of CST1 in both the serum and cancerous tissues of ESCC patients29, and the effect of the miR-942-5p/CST1 axis on the migration and invasion of ESCC cells via the MEK/ERK signaling pathway30. This evidence concerns the gene MAP2K7 and esophageal squamous cell carcinoma.